NCT02153437View on ClinicalTrials.gov

Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers

PHASE1TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 30, 2014

Primary Completion Date

October 20, 2016

Study Completion Date

October 20, 2016

Conditions
Atrial Fibrillation
Interventions
DRUG

BMS-919373

DRUG

Sotalol

DRUG

Placebo for BMS-919373

Trial Locations (6)

78705

Local Institution, Austin

T2N 4N1

The University Of Calgary, Calgary

K1Y 4W7

University Of Ottawa Heart Institute, Ottawa

M5B 1W8

Local Institution - 0001, Toronto

H1T 1C8

Local Institution - 0002, Montreal

H2W 1T8

Local Institution, Montreal

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY